European Leukemia Trial Registry
Trial: NiloRAD (CAMN107ADE01)

More Details
Title AML-NiloRAD (CAMN107ADE01)
Scientific Title An open-label phase I/II (proof of concept) trial of an combination of Nilotinib (AMN107) and RAD001 in patients with acute myeloid leukemia
Short Title NiloRAD (CAMN107ADE01)
Trialgroup NN
Type of Trial multicentric, open-label
Disease Acute myeloid leukemia(AML) AML all subtypes without FAB M3
Age >= 18 years
Status Closed
Start of Recruitment 21.05.2008
Leader Duyster, Prof. Dr., Justus
Contactperson

Study Centre
Röthling, Nadine
Tel: +49 (0)89 4140-6326
Fax: +49 (0)89 4140-6322
Email: n.roethling@lrz.tum.de

Centre of Trial Klinikum rechts der Isar, III. Medizinische Klinik
Shortprotocol Shortprotocol
created 11.12.2008 5 Roswitha Kotthoff
changed 13.11.2014 Alexandra Lucaciu
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org